2018
DOI: 10.1016/j.biopha.2018.02.119
|View full text |Cite
|
Sign up to set email alerts
|

A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 39 publications
0
14
0
Order By: Relevance
“…Another analogue, 3A.1 (19-tert-butyldiphenylsilyl-8, 17-epoxy andrographolide), significantly inhibited TCF/LEF promoter activity [32]. Expression levels of β-catenin and Wnt-stimulated target genes were markedly reduced.…”
Section: Wnt/β-catenin Pathwaymentioning
confidence: 99%
See 1 more Smart Citation
“…Another analogue, 3A.1 (19-tert-butyldiphenylsilyl-8, 17-epoxy andrographolide), significantly inhibited TCF/LEF promoter activity [32]. Expression levels of β-catenin and Wnt-stimulated target genes were markedly reduced.…”
Section: Wnt/β-catenin Pathwaymentioning
confidence: 99%
“…Furthermore, analogue 3A.1 substantially enhanced function of GSK-3 β which promoted β -catenin degradation. The analogue 3A.1 mediated effect was impaired after treatment with GSK-3 β inhibitors or upon the over-expression of mutant β -catenin in colon cancer cells [ 32 ].…”
Section: Wnt/ β -Catenin Pathwaymentioning
confidence: 99%
“…[25][26][27] In this section, we summarize the andrographolide derivatives that have been identified in the past 3 years. These important derivatives include 14-tert-butyl dimethyl silicon-epoxyandrographolide; 28 3-(thiophene-2-carbonyl)−14-deoxy-11, 12 didehydroandrographolide; 29 3-dehydroandrographolide (3-DA); 30 3, 19-diacetyl-14-deoxy-11, 12-didehydroandrographolide (SRS27); 31 3-(2-methoxy-4-nitrophenyl)-andrographolie; 32 3, 14, 19-triacetyl andrographolide (CX-10); 33 AGP-26a (12β-isomer); 34 AGP-26b (12αisomer); 34 14-alpha-lipoic acylandrographolide (AL-1); 35 19-tert-butyldiphenylsilyl-8, 17-epoxy andrographolide; 36 and 19-triisopropyl andrographolide. 37 To some extent, these andrographolide derivatives address the issue of andrographolide's low oral bioavailability.…”
Section: Andrographolide and Its Derivativesmentioning
confidence: 99%
“…Apart from this, the AGP analogues successfully decreases the expression of the active form of β -catenin at the translational level and has the unique ability to function independently of GSK3 β , a negative regulator of Wnt. Interestingly, the analogues can abrogate the nuclear translocation of β -catenin by blocking the Ser675 phosphorylation, thereby causing Wnt inactivation and subsequent cancer regression ( Reabroi et al, 2018a ).…”
Section: Mode Of Action Of Andrographolide In Cancermentioning
confidence: 99%